Guardant Health Lung Cancer

Listing Websites about Guardant Health Lung Cancer

Filter Type:

SHIELD LUNG Study - GuardantHealth

(1 days ago) WebTo accomplish these objectives, Guardant Health is leveraging data from the tens of thousands of cancer patients it has already tested, as well as collaborating with multiple investigators at cancer centers around the world. Guardant Health is addressing this …

https://guardanthealth.com/clinical-studies/shield/

Category:  Cancer Show Health

Home - GuardantHealth

(7 days ago) WebFrom using biomarkers to inform treatment in advanced cancer, to using circulating tumor DNA to not only assess response to treatment, but …

https://guardanthealth.com/

Category:  Cancer Show Health

Clinical Studies - GuardantHealth

(4 days ago) WebGuardant Health liquid biopsy assays have demonstrated ability to help patients with advanced cancer. Now, the next stage is to demonstrate the same effectiveness in early …

https://guardanthealth.com/clinical-studies/

Category:  Cancer Show Health

Guardant Health, Inc. - Guardant Health Presents New Data …

(6 days ago) Web- Multi-Cancer Assay Highly Sensitive and Specific in Screening for Detection of Early-Stage Cancers, Able to Identify Tumor Tissue of Origin with High Accuracy …

https://investors.guardanthealth.com/press-releases/press-releases/2022/Guardant-Health-Presents-New-Data-Showing-Blood-Test-Highly-Accurate-in-Detecting-Multiple-Cancers-at-the-American-Association-for-Cancer-Research-Annual-Meeting/default.aspx

Category:  Cancer Show Health

Guardant Health's Liquid Biopsy Wins in Head-to-Head Trial in …

(2 days ago) WebGuardant Health announced positive results from its NILE study, a head-to-head trial of its Guardant360 compared to standard-of-care tissue testing in first-line …

https://www.biospace.com/article/guardant-s-liquid-biopsy-trial-hits-primary-endpoint-for-lung-cancer/

Category:  Health Show Health

Guardant Health to Present Data From 14 Studies Highlighting …

(7 days ago) WebThe Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs …

https://www.businesswire.com/news/home/20230411005247/en/Guardant-Health-to-Present-Data-From-14-Studies-Highlighting-Advances-in-Precision-Oncology-and-Cancer-Screening-at-2023-AACR-Annual-Meeting

Category:  Health Show Health

Clinical lung cancer – Guardant Health

(7 days ago) WebThis prospective study demonstrated the clinical utility of using ctDNA to guide treatment selection in advanced cancer patients. A quarter of the patients in the NSCLC …

https://guardanthealth.eu/clinical-lung-cancer/

Category:  Cancer Show Health

FDA approves Guardant's tumor-sequencing blood test as a …

(8 days ago) WebGuardant Health received a milestone approval from the FDA for its cancer test, as the first liquid biopsy able to genetically profile solid tumors anywhere in the body …

https://www.fiercebiotech.com/medtech/fda-approves-guardant-s-next-gen-tumor-sequencing-blood-test

Category:  Cancer Show Health

Clinical validation of Guardant360 CDx as a blood-based

(1 days ago) Web9 Guardant Health, Redwood City, CA, USA. Electronic address: [email protected]. 10 Amgen Inc, Thousand Oaks, CA, USA. Electronic …

https://pubmed.ncbi.nlm.nih.gov/34838325/

Category:  Health Show Health

A blood test to help detect lung cancer? New test offered at OSF

(Just Now) WebIf the blood test comes back positive, indicating a possibility of lung cancer, OSF leaders hope patients will then be more likely to agree to a low-dose CT scan.

https://www.chicagotribune.com/2024/05/10/blood-test-lung-cancer-osf-healthcare/

Category:  Cancer Show Health

A blood test to help detect lung cancer? New test offered at 18 …

(1 days ago) WebHarris is among the first group of patients in Illinois to get the blood test as part of a pilot program at health system OSF HealthCare, which is offering the test at 18 …

https://medicalxpress.com/news/2024-05-blood-lung-cancer.html

Category:  Health Show Health

Progress in Lung Cancer, Yet Barriers Remain - GuardantHealth

(8 days ago) WebLung cancer remains one of the most feared cancers, for good reason: Formerly diagnosed at a late stage with rapid progression to death, lung cancer has a …

https://www-1.guardanthealth.com/2022/11/21/progress-in-lung-cancer-yet-barriers-remain/

Category:  Cancer Show Health

Recommendations for reporting tissue and circulating tumour

(Just Now) WebNon-small cell lung cancer is a heterogeneous disease and molecular characterisation plays an important role in its clinical management. Next-generation …

https://www.nature.com/articles/s41416-024-02709-4

Category:  Cancer Show Health

Guardant Health Presents New Data Showing Blood Test

(8 days ago) WebIn January 2022, Guardant Health initiated the SHIELD Lung study, a prospective, observational, multi-center basket study designed to enroll individuals …

https://www.businesswire.com/news/home/20220411005737/en/Guardant-Health-Presents-New-Data-Showing-Blood-Test-Highly-Accurate-in-Detecting-Multiple-Cancers-at-the-American-Association-for-Cancer-Research-Annual-Meeting

Category:  Health Show Health

Guardant Health Enrolls First Patient in SHIELD LUNG Study to …

(6 days ago) WebThe Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs …

https://www.businesswire.com/news/home/20220118005375/en/Guardant-Health-Enrolls-First-Patient-in-SHIELD-LUNG-Study-to-Evaluate-Accuracy-of-Its-Blood-Test-to-Detect-Lung-Cancer-in-High-Risk-Adults

Category:  Health Show Health

Guardant Health Raises Full-Year Guidance as Q1 Revenues Rise …

(7 days ago) WebGuardant Health upped its guidance for the full year, saying it now expects 2024 revenue, excluding screening, to be in the range of $675 million to $685 million, …

https://www.genomeweb.com/molecular-diagnostics/guardant-health-raises-full-year-guidance-q1-revenues-rise-31-percent

Category:  Health Show Health

Guardant Health, Inc. (NASDAQ:GH) Q1 2024 Earnings Call …

(6 days ago) WebGuardant is a liquid biopsy leader for therapy selection with a robust pipeline of opportunities in tissue-free MRD and cancer screening. With our comprehensive suite of …

https://www.msn.com/en-us/money/companies/guardant-health-inc-nasdaq-gh-q1-2024-earnings-call-transcript/ar-BB1mjkJ4

Category:  Cancer Show Health

Guardant Health, Inc. (GH) Q1 2024 Earnings Call Transcript

(6 days ago) Web146.63K Follower s. Guardant Health, Inc. ( NASDAQ: GH) Q1 2024 Earnings Conference Call May 9, 2024 4:30 PM ET. Company Participants. Helmy Eltoukhy - …

https://seekingalpha.com/article/4691776-guardant-health-inc-gh-q1-2024-earnings-call-transcript

Category:  Health Show Health

Guardant Health Receives ‘Buy’ Rating on Strong Q1 Performance …

(Just Now) WebGuardant Health, Inc. is a precision oncology company, which engages in provision of precision oncology testing and development services. It focuses performing …

https://markets.businessinsider.com/news/stocks/guardant-health-receives-buy-rating-on-strong-q1-performance-and-positive-financial-outlook-1033371016

Category:  Health Show Health

Guardant Health to Participate in Upcoming May 2024 Investor

(5 days ago) WebAbout Guardant Health. Guardant Health is a leading precision medicine company focused on guarding wellness and giving every person more time free from …

https://www.biospace.com/article/releases/guardant-health-to-participate-in-upcoming-may-2024-investor-conferences/

Category:  Medicine Show Health

Cancer screening studies - GuardantHealth

(6 days ago) WebGuardant Health liquid biopsy assays have demonstrated ability to help patients with advanced cancer. Now, the next stage is to demonstrate the same effectiveness in early …

https://web.guardanthealth.com/clinical-studies/screening-studies/

Category:  Cancer Show Health

Filter Type: